We are a team of veteran healthcare professionals. We enjoy working with like-minded partners and embrace collaborative approach to successfully achieve business goals.
Myoclonic atonic epilepsy (“MAE”) typically known as Doose
Syndrome is an uncommon childhood epilepsy syndrome that
accounts for 1 to 2 out of 100 (1 to 2%) of all childhood-onset
epilepsies. For parents to know that 2 out of 3 children ultimately
outgrow their epilepsy with proper treatment.
Porphyria (por-FEAR-e-uh) is a group of liver disorders in which substances called porphyrins build up in the body, negatively affecting the skin or nervous system. The types that affect the nervous system are also known as acute porphyria, as symptoms are rapid in onset and short in duration.
Anderson-Fabry disease, also known as Fabry disease, is a rare genetic disease that can affect many parts of the body, including the kidneys, hearts and skin. Fabry disease is one of a group of conditions known as lysosomal storage
disease. The genetic mutation that causes Fabry disease interferes with the
function of any enzyme that processes biomolecules known as sphingolipids, leading to these substances building up in the walls of blood vessels and other organ. It is inherited in an X-linked manner.
Apricus Biopharm is a pharmaceutical company facilitating treatment access and providing special drugs for adults and pediatric patients with rare diseases. We are headquartered in Beijing, China, with offices in Shanghai, Tianjin and Hainan Island Healthcare Pilot Zone BOAO Hope City.
Apricus Biopharm Institute Co., Ltd.
Suite 5-51, Office Building No.5, Jian-Guo-Men-Wai
Diplomatic Residence Compound, Chaoyang District
Beijing, China
We use cookies to ensure that we provide the best possible experience on our website. By continuing, you give your consent for cookies to be used. For more information, including how you can amend your preferences, please read our Cookie Policy.